OPTIMER PHARMACEUTICALS INC Share-based Payment Arrangement, Expense
OPTIMER PHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $2.82 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2013-06-30 was $2.82M, a 28.74% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2013-03-31 was $4.33M, a 40.25% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-12-31 was $2.89M, a 36.76% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $3.07M, a 16.19% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2012 was $13.00M, a 10.17% increase from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2011 was $11.80M, a 84.38% increase from fiscal 2010.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2010 was $6.40M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2013-06-30 | $2.82M 10-Q · filed 2013-08-07 | $7.15M 10-Q · filed 2013-08-07 | $10.04M derived: sum of 3 quarters · filed 2013-08-07 | $13.11M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | $4.33M 10-Q · filed 2013-05-10 | $7.22M derived: sum of 2 quarters · filed 2013-05-10 | $10.29M derived: sum of 3 quarters · filed 2013-05-10 | $14.24M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.96M derived: sum of 2 quarters · filed 2013-03-18 | $9.91M derived: sum of 3 quarters · filed 2013-08-07 | $13.00M 10-K · filed 2013-03-18 |
| 2012-09-30 | $3.07M 10-Q · filed 2012-11-02 | $7.02M derived: sum of 2 quarters · filed 2013-08-07 | $10.11M 10-Q · filed 2012-11-02 | $14.68M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | $3.95M 10-Q · filed 2013-08-07 | $7.04M 10-Q · filed 2013-08-07 | $11.61M derived: sum of 3 quarters · filed 2013-08-07 | $14.25M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | $3.09M 10-Q · filed 2013-05-10 | $7.66M derived: sum of 2 quarters · filed 2013-05-10 | $10.30M derived: sum of 3 quarters · filed 2013-05-10 | $12.76M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $7.21M derived: sum of 2 quarters · filed 2013-03-18 | $9.67M derived: sum of 3 quarters · filed 2013-03-18 | $11.80M 10-K · filed 2013-03-18 |
| 2011-09-30 | $2.64M 10-Q · filed 2012-11-02 | $5.10M derived: sum of 2 quarters · filed 2012-11-02 | $7.23M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $2.46M 10-Q · filed 2012-08-03 | $4.59M 10-Q · filed 2012-08-03 | ||
| 2010-12-31 | $6.40M 10-K · filed 2013-03-18 |